RELONCHEM LTD — Lisinopril Importer Profile
Pharmaceutical Importer · #15 buyer for Lisinopril · $739.4K import value · 38 shipments · UNITED KINGDOM · DGFT Verified
RELONCHEM LTD is the #15 importer of Lisinopril from India with $739.4K in import value and 38 verified shipments. RELONCHEM LTD holds a 0.6% market share in Lisinopril imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 31 formulations shipped to 1 country.
RELONCHEM LTD — Lisinopril Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Lisinopril to RELONCHEM LTD?
Verified from 38 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MARKSANS PHARMA LIMITED | $739.4K | 38 | 100.0% |
RELONCHEM LTD sources Lisinopril from 1 verified Indian supplier based on 38 customs records. The primary supplier is MARKSANS PHARMA LIMITED accounting for 100.0% of imports.
How Does RELONCHEM LTD Compare to Nearest Lisinopril Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | ACTAVIS LABORATORIES FL INC | UNITED STATES | $379.6K | 13 | $29.2K |
| 14 | SHIPALI DERMAN | TURKMENISTAN | $362.0K | 10 | $36.2K |
| 15 | RELONCHEM LTD ★ | UNITED KINGDOM | $345.8K | 15 | $23.1K |
| 7 | LUPIN PHARMACEUTICALS INC | UNITED STATES | $200.0K | 4 | $50.0K |
| 1 | MYLAN B,V, | NETHERLANDS | $150.0K | 3 | $50.0K |
RELONCHEM LTD ranks #15 among 450 Lisinopril importers from India. Average shipment value of $23.1K compared to the market average of $15.6K. The closest competitors by value are ACTAVIS LABORATORIES FL INC and SHIPALI DERMAN.
Where Does RELONCHEM LTD Import Lisinopril To?
Destination countries from 38 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $739.4K | 38 | 100.0% |
RELONCHEM LTD imports Lisinopril to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $739.4K.
What Lisinopril Formulations Does RELONCHEM LTD Import?
| Formulation | Value | Shipments |
|---|---|---|
| LISINOPRIL 10 MG TABLETS BATCH NO: 13013 | $75.5K | 2 |
| PHARMACEUTICAL PRODUCTS - LISINOPRIL 20MG TABLETS Batch No: 150177,150196,150215 | $49.7K | 1 |
| LISINOPRIL 10 MG TABLETS BATCH NO: 131887NOS | $43.5K | 3 |
| LISINOPRIL 10 MG TABLETS BATCH NO: 13083 | $43.1K | 1 |
| LISINOPRIL 20 MG TABLETS BATCH NO: 13083 | $38.3K | 1 |
| LISINOPRIL 20 MG TABLETS BATCH NO: 131863NOS | $37.0K | 3 |
| LISINOPRIL 10 MG TABLETS Batch No: 12138 | $35.3K | 1 |
| PHARMACEUTICAL PRODUCTS LISINOPRIL 20MG TABLETS Batch No 150929 150956 | $35.0K | 1 |
| LISINOPRIL 10 MG TABLETS BATCH NO: 12138 | $35.0K | 1 |
| PHARMACEUTICAL PRODUCTS - LISINOPRIL 5 MG TABLETS Batch No: 150233,150245,150264 | $34.1K | 1 |
RELONCHEM LTD imports 31 distinct Lisinopril formulations from India. The top formulation is LISINOPRIL 10 MG TABLETS BATCH NO: 13013 with 2 shipments worth $75.5K.
Regulatory Requirements: Importing Lisinopril into United Kingdom
What RELONCHEM LTD and other importers must comply with to import Lisinopril from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Lisinopril
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Lisinopril from India and How Much Does RELONCHEM LTD Import?
India exported $7.0M worth of Lisinopril through 3,514 shipments from 221 suppliers to 94 countries, serving 450 buyers globally. RELONCHEM LTD imports $739.4K of this total, accounting for 0.6% of India's Lisinopril exports with 38 shipments from UNITED KINGDOM. This is verified from 38 customs shipment records covering 31 distinct formulations.
What Is the Average Order Value for RELONCHEM LTD's Lisinopril Imports?
RELONCHEM LTD's average Lisinopril order value is $19.5K per consignment, based on 38 shipments totaling $739.4K. RELONCHEM LTD is based in UNITED KINGDOM and ranks #15 among all Lisinopril importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Lisinopril to RELONCHEM LTD?
RELONCHEM LTD sources Lisinopril from 1 verified Indian supplier: MARKSANS PHARMA LIMITED ($739.4K, 100.0%). This is based on 38 customs records.
How Does RELONCHEM LTD Compare to Other Lisinopril Importers?
RELONCHEM LTD ranks #15 among 450 Lisinopril importers from India with a 0.6% market share. The top 3 importers are LUPIN PHARMACEUTICAL INC ($1.4M), BROWN AND BURK UK LIMITED ($852.4K), XXPINXXHARXXCEUXXCALXXINC ($850.0K). RELONCHEM LTD processed 38 shipments from UNITED KINGDOM.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lisinopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lisinopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: RELONCHEM LTD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as RELONCHEM LTD's capped import value divided by total capped export value for Lisinopril across all Indian exporters.
- 5.Verified Records: This page is backed by 38 individual customs records matching RELONCHEM LTD importing Lisinopril, covering 31 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 450+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lisinopril Import Data for RELONCHEM LTD
Access order-level details, pricing data, supplier connections, and competitive analysis for RELONCHEM LTD's Lisinopril imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
RELONCHEM LTD
Company Profile
Multiple products · $0 total trade · Multiple categories
RELONCHEM LTD × Lisinopril
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for RELONCHEM LTD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lisinopril. For current order-level data, contact TransData Nexus.